Monday, 10 November 2014

Competitor Analysis: Anti-Inflammatory Peptides, New Report Launched

Competitor Analysis: Anti-Inflammatory Peptides

The present Competitive Intelligence Report about peptide therapeutics provides a competitor evaluation in the field of marketed and new molecules for treatment of inflammatory and autoimmune diseases as of September 2014. Anti-Inflammatory peptides under development and on the market are used for treatment of diseases ranging from psoriasis, multiple sclerosis, transplantation and autoimmune diseases. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed and active projects in research and development of anti-inflammatory peptides. In addition, the report lists company-specific R&D pipelines of anti-inflammatory peptides.

Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Spanning over 44 pages “Competitor Analysis: Anti-Inflammatory Peptides” report covering 2013 Sales of Major Anti-Inflammatory Peptides, Cardiovascular Diseases, Dermatological Diseases,  Gastrointestinal Diseases, Neurological Diseases, Ophthalmological & Otorhino Diseases, Pulmonary & Respiratory Diseases, Renal Diseases, Rheumatological & Autoimmune Diseases, Transplantation, Not-Specified Inflammatory & Autoimmune Diseases, Corporate Anti-Inflammatory Peptide R&D Pipelines.

Know more about this report athttp://mrr.cm/Zjr

Find all Biotechnology Reports at: http://www.marketresearchreports.com/biotechnology

No comments:

Post a Comment

Note: only a member of this blog may post a comment.